BackAvid Bioservices Overview

Avid Bioservices Minority Interest

Track Avid Bioservices's minority interest ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer average

Loading

Avid Bioservices Minority Interest History

Loading

Avid Bioservices vs. peers: Minority Interest Comparison

Loading

Avid Bioservices Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Avid Bioservices (CDMO) FAQ

Avid Bioservices (CDMO) currently reports a minority interest of $0 as of October 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore Avid Bioservices's minority interest history and peer comparisons.

Avid Bioservices's minority interest changed from $0 to $0 (period ending October 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Avid Bioservices reported $0 in minority interest as of October 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Avid Bioservices, and consider following CDMO for alerts when major investors trade the stock.

Avid Bioservices is classified in the Healthcare sector. On minority interest, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CDMO with unrelated industries.